Cross-reactive cytotoxic T lymphocytes against human immunodeficiency virus type 1 protease and gamma interferon-inducible protein 30

Journal of Virology

Volumn 79, Issue 9, 2005, Pages 5529-5536

  Mason, R D ^a   Bowmer, M I ^b   Howley, C M ^b   Grant, M D ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Health Care Corporation of St John's   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DIMER; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 30; HLA A2 ANTIGEN; IMMUNOGLOBULIN; PROTEINASE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; IN VITRO STUDY; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; T LYMPHOCYTE ACTIVATION;

CELLS, CULTURED; CROSS REACTIONS; HIV INFECTIONS; HIV PROTEASE; HIV-1; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 17444417108     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.9.5529-5536.2005     Document Type: Article

References (29)

1. Acierno, P. M., D. A. Newton, E. A. Brown, L. A. Maes, J. E. Baatz, and S. Gattoni-Celli. 2003. Cross-reactivity between HLA-A2-restricted FLU-MI: 58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals. J. Translational Med. 1:3. [Online.] http://www.translational -medicine.com/ content/1/1/3.
2. Agostini, C., R. Zambello, M. Facco, A. Perin, F. Piazza, M. Silvero, U. Basso, M. Bortolin, L. Trentin, and G. Semenzato. 1999. CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood 93:1277-1286.
3. Arunachalam, B., M. Pan, and P. Cresswell. 1998. Intracellular formation and cell surface expression of a complex of an intact lysosomal protein and MHC class II molecules. J. Immunol. 160:5797-5806.
4. Autran, B., C. M. Mayaud, M. Raphael, F. Plata, M. Denis, A. Bourguin, J. M. Guillon, P. Debre, and G. Akoun. 1988. Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 2:179-185.
5. Calabrese, L. H., M. Estes, B. Yen-Lieberman, M. R. Proffitt, R. Tubbs, A. J. Fishleder, and K. H. Levin. 1989. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis Rheum. 32:569-576.
6. Devergne, O., M. Peuchmaur, M. C. Crevon, J. A. Trapani, M. C. Maillot, P. Galanaud, and D. Emilie. 1991. Activation of cytotoxic cells in hyperplastic lymph nodes from HIV-infected patients. AIDS 5:1071-1079.
7. di Marzo Veronese, F., D. Arnott, V. Barnaba, D. J. Loftus, K. Sakaguchi, C. B. Thompson, S. Salemi, C. Mastroianni, A. Sette, J. Shabanowitz, D. F. Hunt, and E. Appella. 1996. Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects. J. Exp. Med. 183:2509-2516.
8. Dyall, R., W. B. Bowne, L. W. Weber, J. LeMaoult, P. Szabo, Y. Moroi, G. Piskun, J. J. Lewis, A. N. Houghton, and J. Nikolic-Zugic. 1998. Heteroclitic immunization induces tumor immunity. J. Exp. Med. 188:1553-1561.
9. Herberts, C. A., L. van Gaans-van den Brink, E. van der Heeft, M. van Wijk, J. Hoekman, A. Jaye, M. C. Poelen, C. J. Boog, P. J. Roholl, H. Whittle, A. P. de Jong, and C. A. van Els. 2003. Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection. Hum. Immunol. 64:44-55.
10. Hickman, H. D., A. D. Luis, W. Bardet, R. Buchli, C. L. Battson, M. H. Shearer, K. W. Jackson, R. C. Kennedy, and W. H. Hildebrand. 2003. Cutting edge: class I presentation of host peptides following HIV infection. J. Immunol. 171:22-26.
11. Ignatowicz, L., J. Kappler, and P. Marrack. 1996. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84:521-529.
12. Itescu, S., L. J. Branato, J. Buxbaum, P. K. Gregersen, C. C. Rizk, T. S. Croxson, G. E. Solomon, and R. Winchester. 1990. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann. Intern. Med. 112:3-10.
13. Jassoy, C., R. P. Johnson, B. A. Navia, J. Worth, and B. D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
14. Kammer, A. R., S. H. van der Burg, B. Grabscheid, I. P. Hunziker, K. M. Kwappenberg, J. Reichen, J., C. J. Melief, and A. Cerny. 1999. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J. Exp. Med. 190:169-176.
15. Lalvani, A., T. Dong, G. Ogg, A. A. Patham, H. Newell, A. V. Hill, A. J. McMichael, and S. Rowland-Jones. 1997. Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Methods 210:65-77.
16. Li, Q., T. Schacker, J. Carlis, G. Beilman, P. Nguyen, and A. T. Hasse. 2004. Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. J. Infect. Dis. 189:572-582.
17. Luster, A. D., R. L. Weinshank, R. Feinman, and J. V. Ravetch. 1988. Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J. Biol. Chem. 263:12036-12043.
18. Maric, M., B. Arunachalam, U. T. Phan, C. Dong, W. S. Garrett, K. S. Cannon, C. Alfonso, L. Karlsson, R. A. Flavell, and P. Cresswell. 2001. Defective antigen processing in GILT-free mice. Science 294:1361-1365.
19. Mason, R. D., M. I. Bowmer, C. M. Howley, M. Gallant, J. C. E. Meyers, and M. D. Grant. 2004. Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 pol epitopes. J. Immunol. 172: 7212-7219.
20. Misko, I. S., S. M. Cross, R. Khanna, S. L. Elliott, C. Schmidt, S. J. Pye, and S. L. Silins. 1999. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease. Proc. Natl. Acad. Sci. USA 96:2279-2284.
21. Murata, K., and M. C. Dalakas. 1999. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am. J. Pathol. 155:453-460.
22. Ovsyannikova, I. G., K. L. Johnson, S. Naylor, and G. A. Poland. 2000. Isolation and rapid identification of an abundant self-peptide from class II HLA-DRB1*0401 alleles induced by measles vaccine virus infection. J. Immunol. Methods 246:1-12.
23. Salemi, S., A. P. Caporossi, L. Boffa, M. G. Longobardi, and V. Barnaba. 1995. HIV gp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181:2253-2257.
24. Sandberg, J. K., L. Franksson, J. Sundback, J. Michaelsson, M. Petersson, A. Achour, R. P. A. Wallin, N. E. Sherman, T. Bergman, H. Jornvall, D. F. Hunt, R. Kiessling, and K. Karre. 2000. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J. Immunol. 165:25-33.
25. Terasaki, P. I., D. Bernoco, M. S. Park, G. Ozturk, and Y. Iwaki. 1978. Microdroplet testing for HLA-A, -B, -C and -D antigens. Am. J. Clin. Pathol. 69:103-120.
26. van Sechel, A. C., J. J. Bajramovic, M. J. van Stipdonk, C. Persoon-Deen, S. B. Geutskens, and J. M. van Noort. 1999. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J. Immunol. 162:129-135.
27. Villacres, M. C., S. F. Lacey, C. Auge, J. Longmate, J. M. Leedom, and D. J. Diamond. 2003. Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity. J. Infect. Dis. 188: 908-918.
28. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443-446.
29. Yamamoto, H., D. J. Ringler, M. D. Miller, Y. Yasutomi, T. Hasunuma, and N. L. Letvin. 1992. Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys. J. Immunol. 149:728-734.